RxDoctor Payments Data

John Malone, DO

Family Medicine · Hudson, FLNPI 1932415965

Payments from drug & device makers

$3,799in general payments, 2019–2025

Across 216 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Novo Nordisk$326
  • AstraZeneca$310
  • Pfizer$239
  • Boehringer Ingelheim$227
  • Astellas Pharma US Inc$159
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$3,799100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,799 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$13,866
Medicare patients
63
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban68$84,515
JanuviaSitagliptin Phosphate36$49,011
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$47,344
JardianceEmpagliflozin35$46,179
OzempicSemaglutide25$32,051
XareltoRivaroxaban32$20,148
Spiriva RespimatTiotropium Bromide19$11,625
Stiolto RespimatTiotropium Br/Olodaterol Hcl17$9,911
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$9,390
Varenicline Tartrate17$5,731
NovologInsulin Aspart15$4,389
Albuterol Sulfate HfaAlbuterol Sulfate128$4,215
Gabapentin121$4,013
Rosuvastatin Calcium359$3,625
Pregabalin30$2,489

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$239$84,51568 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat$227$67,71671 claims
MerckJanuvia$60$49,01136 claims
GSKTrelegy Ellipta$1,285$47,34454 claims
Novo NordiskOzempic, Novolog$326$36,44040 claims
Johnson & JohnsonXarelto$126$20,14832 claims
AstraZenecaBreztri Aerosphere$310$9,39013 claims
AbbVieSynthroid$17$69623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Hudson

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →